The company's stock shows mixed recent performance with a one-month gain of 6.02% but a three-month decline of 3.91%. Its long-term three-year total shareholder return is strong at nearly 97%. A recent spin-off, Solventum, reported earnings that beat Wall Street estimates. The analysis highlights the need to assess the company's valuation across its diversified segments, noting that strong cash flow doesn't always guarantee superior returns. Broader concerns about tariffs impacting margins are also mentioned in the context of the earnings season.